This move is archived. Current quotes and coverage live on the stock page.
Follow DHB
Delivra Health Brands Inc. (DHB.V) is seeing a positive shift in its stock price, reflecting growing investor confidence.
Today, Delivra's shares rose by 4.76%, closing at CA$0.11. This increase comes as the company expands its presence in the health and wellness sector, which likely contributes to the optimism among investors.
Investor takeaway: Keep an eye on Delivra's product launches and market expansions; these could drive further growth and improve stock performance.
Advertisement
Delivra Health Brands Inc.
DHB.V
DHB.V
Delivra Health Brands Inc.
WealthAwesomeMarket cap
$3.13M
52W high
$0.35
52W low
$0.07
1W change
+17.65%
Beta
0.88
Analyst Price Targets
Based on analyst covering DHB · as of Sep 17, 2026
Wall Street analysts forecast DHB stock price to rise 430.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.53
+430.0% Upside
Current Price
C$0.10
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on DHB's historical volatility
30-Day Vol
170.2%
Annualized
90-Day Vol
133.7%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$0.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.10 | C$0.06 – C$0.18 |
| 60 trading days | C$0.10 | C$0.04 – C$0.23 |
| 90 trading days | C$0.10 | C$0.04 – C$0.28 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
DHB.V Stock Up 4.76% Today
The stock's rise to CA$0.11 gives it a market cap of approximately CA$3.28 million, indicating that it’s a small-cap company with potential for growth.
Bull case
The recent launch of LivRelief™ Itch Relief Cream in Canada could be a significant growth driver. This product may attract new customers and boost revenue for Delivra Health Brands.
Bear case
Despite today's gains, Delivra Health Brands faces challenges, including a negative profit margin and the need for consistent revenue growth to maintain investor confidence.
Market Reaction to Product Launch
Advertisement
The launch of LivRelief™ Itch Relief Cream has likely piqued investor interest, showcasing Delivra's commitment to expanding its product line. This strategic move positions the company to capture a larger share of the health and wellness market, which is crucial for growth.
Financial Health Overview
While Delivra Health Brands is enjoying a positive stock movement today, it’s important to consider its financial health. With a negative profit margin of -0.0899, the company needs to focus on improving profitability to sustain investor confidence and support further increases in stock price.
Future Outlook
Looking ahead, investors should watch Delivra's upcoming product launches and market strategies. The company’s ability to innovate and effectively market its products will be key to maintaining its upward momentum in the stock market.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
